VPRIV home infusion educational materials survey
Part of Brain & nervous system, Genetic & congenital, Hormones & metabolism clinical trials.
This survey asks people with Gaucher disease, their caregivers, and home infusion nurses about how they use and understand the educational materials for VPRIV home infusion. Your answers can help improve these materials for others.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have Gaucher disease and take VPRIV at home, or you are a caregiver for someone who does.
- You are a nurse who gives VPRIV infusions at home to people with Gaucher disease.
- You are not employed by a regulatory body or pharmaceutical company.
- You are willing to answer a survey about how you use and understand the educational materials for VPRIV home infusion.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how Gaucher disease affects patients’ daily life and health outcomes through a survey. Your answers could help improve future care and treatments by showing what outcomes matter most.
This study looks at the nutrition and diet of people with Gaucher disease. It may help doctors understand how to better support patients' health.
This study is designed to learn what happens over time in people who have Gaucher disease. It may help researchers understand the long-term effects of the condition and improve future care.
This study looks for tiny particles in blood (called extracellular vesicles) that may help identify Gaucher disease and could guide future treatments. It also studies people who have Gaucher gene carrier status but do not have the disease, using careful genetic testing.
This study looks at how standard treatments for Gaucher disease affect lung problems, bone damage, and parkinson-like symptoms. It aims to find better ways to treat these complications and improve quality of life.
This study creates a large, long-term record of people with Gaucher disease and details about pregnancy outcomes. It helps researchers better understand Gaucher over a person’s life and during pregnancy.
Hear when a new Gaucher Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.